Dr. Akhila Kosaraju – Pioneer of AI-Powered Antibiotic Discovery
In the urgent race against antimicrobial resistance, Dr. Akhila Kosaraju is redefining drug discovery as CEO and President of Phare Bio. A physician and innovator with deep expertise in infectious diseases and computational biology, she leads a social venture that harnesses generative AI and deep learning to design novel classes of antibiotics targeting the world's most dangerous drug-resistant pathogens. By accelerating what once took years into months, her team is creating breakthrough therapies that could save millions of lives. Kosaraju's leadership blends scientific rigor with a mission-driven ethos, turning Phare Bio into a beacon of hope in global health. In 2026, as antibiotic resistance continues to escalate, her visionary work demonstrates how AI can be harnessed not just for speed, but for responsible, impactful innovation that prioritizes humanity's most pressing medical needs.
